- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03659591
Triple Aim Psychotherapy: Aimed at Improving Patient Experience, Population Health, and Cost (TAP)
Triple Aim Psychotherapy: an RCT Comparing Cognitive Behaviour Therapy (CBT) to Adaptive Psychological Training (APT) - a Treatment Aimed at Improving Patient Experience, Population Health, and Cost-effectiveness
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Depression and anxiety are highly prevalent in the general population. Community mental health programs in publically-funded jurisdictions such as Canada often have relatively limited, fixed budgets in order to provide services, which can result in inadequate access to effective treatment for patients. Cognitive Behaviour Therapy (CBT) is a gold-standard psychotherapeutic treatment for depression and anxiety. In order to improve access to treatment, community mental healthcare settings often provide CBT in a group format for patients experiencing mild-to-moderate symptoms. However, typical protocols for delivering group CBT in a community setting nonetheless require a considerable investment of limited clinician time.
The question arises as to whether this is the most efficient and effective use of clinician time; in other words, per hour spent of clinician time, does this approach maximize the number of patients experiencing adequate and meaningful clinical improvement? The Institute for Healthcare Improvement (IHI) developed the Triple Aim, which is a framework describing an approach to optimizing health system performance by simultaneously pursuing three dimensions, namely improving the patient experience of care; improving the health of populations; and reducing the associated per capita costs of care. Studies of psychotherapy rarely pursue all three of these dimensions simultaneously. Efforts to achieve the best clinical outcome for an individual often lead to restrictive inclusionary/exclusionary criteria that sacrifice reaching the wider population; conversely, efforts to improve population health often prioritize composite overall clinical improvement across an entire group, even though the change experienced by many of the individuals in the population might not be clinically meaningful; focusing primarily on cost-effectiveness often sacrifices the individual's experience and/or the population's needs.
Adaptive Psychological Training (APT) is a group-based psychotherapy designed with all of the dimensions of the Triple Aim in mind simultaneously. In its development, APT drew heavily upon Mindfulness-Based Cognitive Therapy, an evidence-based psychotherapy that itself draws upon both evidence-based eastern psychotherapeutic practices and CBT, but APT also drew upon other evidence-based and evidence-supported psychotherapies including interpersonal and relational approaches, as well as meaning-focused psychoanalytic models. It also drew from psychology and neuroscience more broadly, as well as from learning theory and from practical clinical and operational experience. Inclusion/exclusion criteria, group size, number of sessions, in-session practice and learning, and between-session practice and learning were all adapted from the perspective of trying to achieve high quality outcomes for a broader population within more contained costs, and thereby increase access to quality care.
To-date, APT has already demonstrated positive outcomes in pilot research and in community clinical settings. The purpose of this specific study is to determine whether for a given population of patients experiencing mild-to-moderate symptoms of depression and/or anxiety, APT can facilitate meaningful change for more patients per time spent by clinicians than can CBT (the gold standard). The significance of this study includes its potential contribution to determining how best to deploy the limited resource of clinician time in a community setting in order to best help the most people.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Ontario
-
Burlington, Ontario, Canada, L7S OA2
- Joseph Brant Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Treatment-seeking adults, interested and willing to participate in group psychotherapy
- Mild-to-moderate depressive (score of ≥10 and <20 on PHQ9) and/or anxious (score of ≥8 and <15 on GAD7) symptoms
- Ability to communicate, in written and spoken English
Exclusion Criteria:
- Severe depressive/anxious symptoms
- Patients where the primary clinical focus is active suicidality or harm-to-others, psychosis, mania, substance use, posttraumatic stress, or personality pathology such that it would interfere with group function
- Recent course(s) of the study psychotherapies
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Cognitive Behaviour Therapy
10 week, manual-based group CBT treatment for depression and anxiety, followed by optional booster sessions
|
CBT will be delivered in group format, consisting of 10 weekly two-hour sessions, with 10 participants per group
Andre navne:
|
|
Aktiv komparator: Adaptive Psychological Training
5 week, manual-based group APT treatment for depression and anxiety, followed by optional booster sessions
|
APT will be delivered in group format, consisting of 5 weekly two-hour sessions, with 20 participants per group
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Triple Aim Measure
Tidsramme: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
Numerator: The number of patients achieving reliable recovery; denominator: clinician time spent in hours ('reliable recovery' is defined as scores below 'caseness' for both depression [<10 on Patient Health Questionnaire (PHQ-9)] and anxiety [<8 on Generalized Anxiety Disorder-7 (GAD-7)], with any change from above caseness to below caseness meeting the threshold of the Reliable Change Index)
|
At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Triple Aim Measure - recovery only
Tidsramme: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
Triple Aim Composite Score (as above), but without the Reliable Change Index requirement
|
At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
|
Triple Aim Measure - improvement only
Tidsramme: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
Triple Aim Composite Score (as above), but without the remission requirement
|
At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months
|
|
Change from baseline - depressive symptoms
Tidsramme: Pre- (week 0) and repeated every two weeks across 6 months
|
Scale used to measure depressive symptoms is the Patient Health Questionnaire (PHQ-9); score ranges from 0-27, where higher values indicate more depressive symptoms (worse outcome)
|
Pre- (week 0) and repeated every two weeks across 6 months
|
|
Change from baseline - anxiety symptoms
Tidsramme: Pre- (week 0) and repeated every two weeks across 6 months
|
Scale used to measure anxiety symptoms is the Generalized Anxiety Disorder 7-item (GAD-7) Scale; score ranges from 0-21, where higher values indicate more anxiety symptoms (worse outcome)
|
Pre- (week 0) and repeated every two weeks across 6 months
|
|
Change from baseline - function
Tidsramme: Pre- (week 0) and repeated monthly across 6 months
|
Scale used to measure function is the World Health Organization Disability Assessment Schedule 2.0 - 12 item version (WHODAS 2.0 12-item); score ranges from 0-48, where higher values indicate lower functioning (worse outcome)
|
Pre- (week 0) and repeated monthly across 6 months
|
|
Change from baseline - mental wellbeing
Tidsramme: Pre- (week 0) and repeated monthly across 6 months
|
Scale used to measure mental wellbeing is the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS); score ranges from 14-70, where higher values indicate greater mental wellbeing (better outcome)
|
Pre- (week 0) and repeated monthly across 6 months
|
|
Change from baseline - self-compassion
Tidsramme: Pre- (week 0) and repeated monthly across 6 months
|
Scale used to measure self-compassion is the Self-Compassion Scale - Short Form (SCS-SF); score ranges from 12-60, where higher values indicate greater self-compassion (better outcome)
|
Pre- (week 0) and repeated monthly across 6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Steven Selchen, MD MSt FRCPC, Joseph Brant Hospital
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 000-044-18
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Depressive symptomer
-
Universidad de CórdobaUniversity Hospital Reina Sofia, Cordoba; State Research Agency, SpainIkke rekrutterer endnuGeneraliseret angstlidelse | Angst | Somatoforme lidelser | Generaliseret angst | Følelsesmæssige forstyrrelser | Depression - svær depressiv lidelse | Somatisering | Somatisk Symptom Disorder (DSM-5)Spanien
-
China Academy of Chinese Medical SciencesUkendtDepressiv lidelse | Depression | Depressivt symptomKina
-
Trakya UniversityAfsluttetDysmenoré | Mestringsadfærd | Musik | Tegning | Symptom, depressiv | Dysmenoré SymptomKalkun
-
MetroHealth Medical CenterAfsluttetDepression | Hæmodialyse-induceret symptomForenede Stater
-
Hospital de Sant PauInstituto de Salud Carlos IIIAfsluttetStørre depressiv lidelse | Kognitivt symptomSpanien
-
University Medical Center GroningenMartini Hospital GroningenAfsluttet
-
Fundación SenefroBaxter Healthcare CorporationUkendtHæmodialyse-induceret symptomSpanien
-
All India Institute of Medical Sciences, BhubaneswarRekrutteringSomatisk Symptom Disorder (DSM-V)Indien
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityIkke rekrutterer endnuUreteral stent-relateret symptom
-
Queen's University, BelfastAfsluttetSymptom på indtrængenDet Forenede Kongerige
Kliniske forsøg med Cognitive Behaviour Therapy
-
Utah State UniversityUkendt
-
NYU Langone HealthTrukket tilbageInflammatorisk tarmsygdomForenede Stater
-
Hacettepe UniversityTilmelding efter invitationMotorisk aktivitet | Executive dysfunktion | Kognitiv orienteringKalkun
-
University of ArizonaUniversity of Colorado, DenverUkendt
-
Assiut UniversityIkke rekrutterer endnuPsykisk lidelse hos børn | Børns adfærdsforstyrrelser | Teenagers adfærdsforstyrrelseEgypten
-
Nanjing Medical UniversityTilmelding efter invitationMavekræft (GC) | Skrøbelighed i voksenkirurgiKina
-
Ankara UniversityIkke rekrutterer endnu
-
IRCCS Eugenio MedeaAfsluttetAutismespektrumforstyrrelse | Tidlig indsatsItalien
-
Koç UniversityAfsluttetDiabetes mellitus, svangerskabssygeKalkun
-
RANDNational Institute on Minority Health and Health Disparities (NIMHD); Clinical...RekrutteringCOVID-19-vaccinationForenede Stater